WallStreetZenWallStreetZen

NASDAQ: FIXX
Homology Medicines Inc Stock

Open Broker Account
$1.38-0.05 (-3.5%)
Updated Dec 9, 2022
FIXX Price
$1.38
Fair Value Price
$2.13
Market Cap
$79.32M
52 Week Low
$1.30
52 Week High
$4.56
P/E
-17.25x
P/B
0.38x
P/S
28.83x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.21M
Earnings
-$4.29M
Gross Margin
100%
Operating Margin
-108.39%
Profit Margin
-133.8%
Debt to Equity
0.26
Operating Cash Flow
-$117M
Beta
1.2
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

FIXX Overview

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, cardiac and skeletal muscle, and eye. Its lead product candidate is HMI-102, which is in Phase 2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; HMI-202 to treat metachromatic leukodystrophy; and HMI-203 for the treatment of mucopolysaccharidosis type II, as well as HMI-104 for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how FIXX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

FIXX ($1.38) is undervalued by 35.25% relative to our estimate of its Fair Value price of $2.13 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
FIXX ($1.38) is significantly undervalued by 35.25% relative to our estimate of its Fair Value price of $2.13 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
FIXX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more FIXX due diligence checks available for Premium users.

Be the first to know about important FIXX news, forecast changes, insider trades & much more!

FIXX News

Valuation

FIXX fair value

Fair Value of FIXX stock based on Discounted Cash Flow (DCF)
Price
$1.38
Fair Value
$2.13
Undervalued by
35.25%
FIXX ($1.38) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
FIXX ($1.38) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
FIXX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

FIXX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-17.25x
Industry
13.17x
Market
21.21x

FIXX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.38x
Industry
4.91x
FIXX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

FIXX's financial health

Profit margin

Revenue
$802.0k
Net Income
-$33.7M
Profit Margin
-4,205.2%
FIXX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
FIXX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$262.7M
Liabilities
$53.6M
Debt to equity
0.26
FIXX's short-term assets ($213.20M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FIXX's short-term assets ($213.20M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FIXX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$24.9M
Investing
-$108.2M
Financing
$124.0k
FIXX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

FIXX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
FIXX$79.32M-3.50%-17.25x0.38x
ENLV$79.35M0.00%-2.75x1.25x
ETON$78.93M+1.63%-8.91x7.06x
IOBT$80.39M-0.36%0.01x0.52x
VTVT$81.57M-2.99%-2.60x-4.92x

Homology Medicines Stock FAQ

What is Homology Medicines's quote symbol?

NASDAQ: FIXX) Homology Medicines trades on the NASDAQ under the ticker symbol FIXX. Homology Medicines stock quotes can also be displayed as NASDAQ: FIXX.

If you're new to stock investing, here's how to buy Homology Medicines stock.

What is the 52 week high and low for Homology Medicines (NASDAQ: FIXX)?

(NASDAQ: FIXX) Homology Medicines's 52-week high was $4.56, and its 52-week low was $1.30. It is currently -69.74% from its 52-week high and 6.15% from its 52-week low.

How much is Homology Medicines stock worth today?

(NASDAQ: FIXX) Homology Medicines currently has 57,480,610 outstanding shares. With Homology Medicines stock trading at $1.38 per share, the total value of Homology Medicines stock (market capitalization) is $79.32M.

Homology Medicines stock was originally listed at a price of $18.66 in Mar 28, 2018. If you had invested in Homology Medicines stock at $18.66, your return over the last 4 years would have been -92.6%, for an annualized return of -47.85% (not including any dividends or dividend reinvestments).

How much is Homology Medicines's stock price per share?

(NASDAQ: FIXX) Homology Medicines stock price per share is $1.38 today (as of Dec 9, 2022).

What is Homology Medicines's Market Cap?

(NASDAQ: FIXX) Homology Medicines's market cap is $79.32M, as of Dec 10, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Homology Medicines's market cap is calculated by multiplying FIXX's current stock price of $1.38 by FIXX's total outstanding shares of 57,480,610.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.